World Top 100 Biotechnology Companies List by Market Cap as of August 2026

World Top 100 Biotechnology Companies List by Market Cap as of August 2026, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as of August 2026.

World Top Biotechnology Companies in 2026
World Largest Biotechnology Companies by Market Cap in 2026, World Top Biotechnology Companies by Market Cap in 2026.

  1. Prevail Therapeutics

    World Rank (Aug-2026)
    8,965
    World Rank (Jan-05-2024)
    8,965
    World Rank (Jul-30-2023)
    8,965
    World Rank (Dec-25-2022)
    8,965
    World Rank (Jan-07-2022)
    8,965
    Annual Operating Income in USD
    -66 Million USD
    Annual Net Income in USD
    -63 Million USD
    Annual Results for Period Ending
    For year ending December-2019
    Headquarters Country
    USA
    Company Profile
    Prevail Therapeutics is a Clinical Stage Biotechnology company seeking to improve lives through the curative potential of gene therapy. The headquarters is in USA.
    Company Website
    PREVAIL THERAPEUTICS

  2. Sana Biotechnology Inc.

    World Rank (Aug-2026)
    8,966
    Market Cap (Aug-2026)
    1.063 Billion USD
    World Rank (Jan-05-2024)
    8,761
    Market Cap (Jan-05-2024)
    0.966 Billion USD
    World Rank (Jul-30-2023)
    8,207
    Market Cap (Jul-30-2023)
    1.115 Billion USD
    World Rank (Dec-25-2022)
    10,819
    Market Cap (Dec-25-2022)
    0.647 Billion USD
    World Rank (Jan-07-2022)
    5,595
    Market Cap (Jan-07-2022)
    2.40 Billion USD
    Annual Operating Income in USD
    -250 Million USD
    Annual Net Income in USD
    -244 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Website
    SANA BIOTECHNOLOGY, INC.

  3. Brooklyn Immunotherapeutics Inc.

    World Rank (Aug-2026)
    8,971
    Market Cap (Aug-2026)
    1.063 Billion USD
    World Rank (Jan-05-2024)
    18,926
    World Rank (Jul-30-2023)
    18,926
    World Rank (Dec-25-2022)
    18,926
    World Rank (Jan-07-2022)
    18,926
    Market Cap (Jan-07-2022)
    0.20 Billion USD
    Annual Operating Income in USD
    -9 Million USD
    Annual Net Income in USD
    -14 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Profile
    Brooklyn ImmunoTherapeutics is a Clinical Stage Biopharmaceutical company committed to creating a world where patients and families with high unmet medical needs have access to effective treatments. The company annual revenue is 5.8 million USD. The headquarters is in USA.
    Company Website
    BROOKLYN IMMUNOTHERAPEUTICS, INC.

  4. Green Cross Corporation

    World Rank (Aug-2026)
    8,977
    Market Cap (Aug-2026)
    1.060 Billion USD
    World Rank (Jan-05-2024)
    8,365
    Market Cap (Jan-05-2024)
    1.048 Billion USD
    World Rank (Jul-30-2023)
    8,787
    Market Cap (Jul-30-2023)
    0.991 Billion USD
    World Rank (Dec-25-2022)
    7,469
    Market Cap (Dec-25-2022)
    1.217 Billion USD
    World Rank (Jan-07-2022)
    6,341
    Market Cap (Jan-07-2022)
    1.97 Billion USD
    Annual Revenue in USD
    1,150 Million USD
    Annual Net Income in USD
    92 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    South Korea
    Yahoo @ SouthKorea
    Company Profile
    Green Cross Corporation is a biotechnology company focused on research, development and provision of a broad array of pharmaceutical products, medical devices and healthcare services for better global prevention, diagnosis and treatment of diseases of the body and mind. The company annual revenue is 1,537,825 million KRW and annual net income is 123,211 million KRW as on 2021. The headquarters is in South Korea.
    Company Website
    GREEN CROSS CORPORATION

  5. Avalo Therapeutics Inc.

    World Rank (Aug-2026)
    9,013
    Market Cap (Aug-2026)
    1.051 Billion USD
    World Rank (Jan-05-2024)
    31,979
    Market Cap (Jan-05-2024)
    0.007 Billion USD
    World Rank (Jul-30-2023)
    33,602
    Market Cap (Jul-30-2023)
    0.003 Billion USD
    World Rank (Dec-25-2022)
    25,537
    Market Cap (Dec-25-2022)
    0.047 Billion USD
    World Rank (Jan-07-2022)
    21,658
    Market Cap (Jan-07-2022)
    0.12 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -73 Million USD
    Annual Net Income in USD
    -78 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Profile
    Avalo Therapeutics, Inc. is a biopharmaceutical company that discover, develop and commercialize highly targeted therapeutics in areas of significant unmet clinical need. The headquarters is in USA.
    Facts About Company
    Avalo Therapeutics, Inc. company annual revenue is 18 million USD and annual net loss -41 million USD as on Dec-2022.
    Company Website
    AVALO THERAPEUTICS, INC.

  6. Hainan Huluwa Pharmaceutical Group Co. Ltd

    World Rank (Aug-2026)
    9,060
    Market Cap (Aug-2026)
    1.041 Billion USD
    World Rank (Jan-05-2024)
    9,489
    Market Cap (Jan-05-2024)
    0.845 Billion USD
    World Rank (Jul-30-2023)
    9,527
    Market Cap (Jul-30-2023)
    0.859 Billion USD
    World Rank (Dec-25-2022)
    8,289
    Market Cap (Dec-25-2022)
    1.017 Billion USD
    World Rank (Jan-07-2022)
    7,314
    Market Cap (Jan-07-2022)
    1.55 Billion USD
    Headquarters Country
    China
    Company Website
    HAINAN HULUWA PHARMACEUTICAL GROUP CO., LTD.

  7. GNI Group

    World Rank (Aug-2026)
    9,092
    Market Cap (Aug-2026)
    1.038 Billion USD
    World Rank (Jan-05-2024)
    9,062
    Market Cap (Jan-05-2024)
    0.915 Billion USD
    World Rank (Jul-30-2023)
    13,995
    Market Cap (Jul-30-2023)
    0.410 Billion USD
    World Rank (Dec-25-2022)
    13,412
    Market Cap (Dec-25-2022)
    0.430 Billion USD
    World Rank (Jan-07-2022)
    12,613
    Market Cap (Jan-07-2022)
    0.57 Billion USD
    Annual Revenue in USD
    93 Million USD
    Annual Net Income in USD
    8 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Japan
    Yahoo @ Tokyo
    Company Website
    GNI GROUP

  8. Lexicon Pharmaceuticals

    World Rank (Aug-2026)
    9,111
    Market Cap (Aug-2026)
    1.032 Billion USD
    World Rank (Jan-05-2024)
    14,138
    Market Cap (Jan-05-2024)
    0.390 Billion USD
    World Rank (Jul-30-2023)
    12,951
    Market Cap (Jul-30-2023)
    0.485 Billion USD
    World Rank (Dec-25-2022)
    14,430
    Market Cap (Dec-25-2022)
    0.368 Billion USD
    World Rank (Jan-07-2022)
    13,051
    Market Cap (Jan-07-2022)
    0.53 Billion USD
    Annual Revenue in USD
    50 Million USD
    Annual Operating Income in USD
    -49 Million USD
    Annual Net Income in USD
    -50 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ MunichGermany
    Company Profile
    Lexicon Pharmaceuticals is a Biopharmaceutical company that is applying a unique approach to gene science based on Nobel Prize winning technology to discover and develop precise medicines for people with serious, chronic conditions. The company annual revenue is 322.07 million USD and 202 employees as on 2019. The headquarters is in USA.
    Company Website
    LEXICON PHARMACEUTICALS
    Wikipedia
    Wikipedia

  9. Ardelyx

    World Rank (Aug-2026)
    9,194
    Market Cap (Aug-2026)
    1.012 Billion USD
    World Rank (Jan-05-2024)
    6,971
    Market Cap (Jan-05-2024)
    1.428 Billion USD
    World Rank (Jul-30-2023)
    9,735
    Market Cap (Jul-30-2023)
    0.828 Billion USD
    World Rank (Dec-25-2022)
    13,070
    Market Cap (Dec-25-2022)
    0.452 Billion USD
    World Rank (Jan-07-2022)
    22,233
    Market Cap (Jan-07-2022)
    0.11 Billion USD
    Annual Revenue in USD
    407 Million USD
    Annual Operating Income in USD
    -41 Million USD
    Annual Net Income in USD
    -62 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Profile

    Ardelyx is a Biotechnology company enabled to develop a pipeline of drug candidates designed to better manage complications related to kidney and cardiorenal diseases. The headquarters is in USA.

    Facts About Company

    Ardelyx Annual Total Revenue for year ending Dec-2022 was 52 million USD and and Net loss for year ending Dec-2022 was -67 million USD.

    Ardelyx Annual Total Revenue for year ending Dec-2021 was 10 million USD and and Net loss for year ending Dec-2021 was -158 million USD.

    As on 2022, Ardelyx has 133 employees.

    Company Website
    ARDELYX

  10. Sosei Group Corporation

    World Rank (Aug-2026)
    9,219
    Market Cap (Aug-2026)
    1.006 Billion USD
    World Rank (Jan-05-2024)
    9,415
    Market Cap (Jan-05-2024)
    0.857 Billion USD
    World Rank (Jul-30-2023)
    8,445
    Market Cap (Jul-30-2023)
    1.061 Billion USD
    World Rank (Dec-25-2022)
    7,181
    Market Cap (Dec-25-2022)
    1.301 Billion USD
    World Rank (Jan-07-2022)
    8,410
    Market Cap (Jan-07-2022)
    1.22 Billion USD
    Annual Revenue in USD
    129 Million USD
    Annual Net Income in USD
    7 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Japan
    Yahoo @ Tokyo
    Company Profile
    Sosei Group Corp discovers, designs and develops medicines targeting G protein-coupled receptors (GPCRs) company. The company annual revenue is 17,712 million JPY and annual net income is 1,017 million JPY for year ending December 2021. The headquarters is in Japan.
    Company Website
    SOSEI GROUP CORPORATION

Share